Drug development and open access: approaches and perspectives
Open Access
- 15 August 2018
- journal article
- Published by Doctrina, Ltd. in Microbiology Independent Research Journal (MIR Journal)
Abstract
The development of a new medicine is a process that requires enormous time and tremendous financing. It takes 10-15 years from the discovery of an active compound to the launch of its production and the start of drug marketing with the total costs of the project reaching 1.8 billion US dollars. These large time and financial costs stem from repeated testing and elimination of a large percentage of compounds over the course of screening at each stage of preclinical and clinical trials. Many investors have lost interest in financing new drug discovery projects (or pharmaceutical start-up companies) due to the high risk and extensive time required to produce a return on investments. Since all the research data are considered confidential by pharmaceutical companies and thus never shared with scientific community, different scientific groups waste significant resources repeating the same costly experiments in drug discovery. In this article, we discuss new approaches to drug discovery involving open access to the research data and alternative financing that could significantly streamline the search for new cures for human diseases.Keywords
This publication has 11 references indexed in Scilit:
- Institutional profile: Community for Open Antimicrobial Drug Discovery – crowdsourcing new antibiotics and antifungalsFuture Science OA, 2017
- WONKAandOOMMPPAA: analysis of protein–ligand interaction data to direct structure-based drug designActa crystallographica. Section D, Structural biology, 2017
- Discovery of Potent and Selective Inhibitors for G9a-Like Protein (GLP) Lysine MethyltransferaseJournal of Medicinal Chemistry, 2017
- Open Targets: a platform for therapeutic target identification and validationNucleic Acids Research, 2016
- Chemical philanthropy: a path forward for antibiotic discovery?Future Medicinal Chemistry, 2016
- Open Access Could Transform Drug Discovery: A Case Study of JQ1Expert Opinion on Drug Discovery, 2016
- A community-based approach to new antibiotic discoveryNature Reviews Drug Discovery, 2015
- Open Access Target Validation Is a More Efficient Way to Accelerate Drug DiscoveryPLoS Biology, 2015
- Collaboration for rare disease drug discovery researchF1000Research, 2014
- Physicochemical Properties of Antibacterial Compounds: Implications for Drug DiscoveryJournal of Medicinal Chemistry, 2008